. . "\u00DAVOD: Prevalence metabolick\u00E9ho syndromu (MS) v d\u011Btsk\u00E9 a adolescentn\u00ED populaci z\u00E1vis\u00ED na jeho definici a v Evrop\u011B se pohybuje kolem 1%. Stejn\u011B jako u dosp\u011Bl\u00FDch stoup\u00E1 s rostouc\u00ED t\u011Blesnou hmotnost\u00ED, u d\u011Bt\u00ED s nadv\u00E1hou \u010Di obezitou se pohybuje od 16 % do 36 % v z\u00E1vislosti na pou\u017Eit\u00E9 definici. Pacienti s chronickou ren\u00E1ln\u00ED insuficienc\u00ED maj\u00ED v\u00FDznamn\u011B vy\u0161\u0161\u00ED riziko kardiovaskul\u00E1rn\u00EDch komplikac\u00ED, to se po transplantaci ledviny sni\u017Euje pouze \u010D\u00E1ste\u010Dn\u011B. Prevalence MS v t\u00E9to populaci dosahuje a\u017E 68 %. METODIKA: Pr\u016F\u0159ezov\u011B jsme vy\u0161et\u0159ili 28 pacient\u016F s transplantovanou ledvinou (v\u011Bk 6\u201318 let, 16 d\u00EDvek). Metabolick\u00FD syndrom byl definov\u00E1n jako p\u0159\u00EDtomnost t\u0159\u00ED a v\u00EDce rizikov\u00FDch faktor\u016F (RF): la\u010Dn\u00E1 glyk\u00E9mie 6,1 mmol/l; Z-sk\u00F3re BMI 2; hladina triglycerid\u016F 1,1 mmol/l; hladina HDL-cholesterolu 1,3 mmol/l ( 1,17 mmol/l pro chlapce 15\u201319 let); hodnoty krevn\u00EDho tlaku > 95. percentil \u010Di pot\u0159eba antihypertenzn\u00ED terapie. U podskupiny z\u00E1kladn\u00EDho souboru (n = 10) jsme provedli z\u00E1t\u011B\u017Eov\u00FD test do maxima."@cs . . "CZ - \u010Cesk\u00E1 republika" . . . . "INTRODUCTION: Prevalence of metabolic syndrome (MS) depends on its definition and varies about 1 % in European child and adolescent population. Like in adults it increases with increasing body weight. In overweight and obese children prevalence of MS varies between 16%and 36%depending on used definition. Patients with chronic kidney disease are at higher risk of developing cardiovascular complications. Reduction of this risk after renal transplantation is just partial. Prevalence of MS in this population reaches as far as 68 %. METHODOLOGY: Cross-sectional survey of 28 kidney recipients (age 6\u201318, 16 girls). Metabolic syndrome was defined as a presence of three or more risk factors (RF): fasting glucose 6,1 mmol/l; BMI 2,0 SD of reference values for age and sex (> 25 for patients older than 18 years); triglycerides level 1,1 mmol/l; HDL-cholesterol level 1,3 mmol/l ( 1,17 mmol/l for boys aged 15\u201319); blood pressure values > 95. percentile or requirement of antihypertensive therapy."@en . "Prevalence metabolick\u00E9ho syndromu a t\u011Blesn\u00E1 zdatnost u d\u011Bt\u00ED a dosp\u00EDvaj\u00EDc\u00EDch s transplantovanou ledvinou \u2013 p\u0159edb\u011B\u017En\u00E9 v\u00FDsledky" . . "\u00DAVOD: Prevalence metabolick\u00E9ho syndromu (MS) v d\u011Btsk\u00E9 a adolescentn\u00ED populaci z\u00E1vis\u00ED na jeho definici a v Evrop\u011B se pohybuje kolem 1%. Stejn\u011B jako u dosp\u011Bl\u00FDch stoup\u00E1 s rostouc\u00ED t\u011Blesnou hmotnost\u00ED, u d\u011Bt\u00ED s nadv\u00E1hou \u010Di obezitou se pohybuje od 16 % do 36 % v z\u00E1vislosti na pou\u017Eit\u00E9 definici. Pacienti s chronickou ren\u00E1ln\u00ED insuficienc\u00ED maj\u00ED v\u00FDznamn\u011B vy\u0161\u0161\u00ED riziko kardiovaskul\u00E1rn\u00EDch komplikac\u00ED, to se po transplantaci ledviny sni\u017Euje pouze \u010D\u00E1ste\u010Dn\u011B. Prevalence MS v t\u00E9to populaci dosahuje a\u017E 68 %. METODIKA: Pr\u016F\u0159ezov\u011B jsme vy\u0161et\u0159ili 28 pacient\u016F s transplantovanou ledvinou (v\u011Bk 6\u201318 let, 16 d\u00EDvek). Metabolick\u00FD syndrom byl definov\u00E1n jako p\u0159\u00EDtomnost t\u0159\u00ED a v\u00EDce rizikov\u00FDch faktor\u016F (RF): la\u010Dn\u00E1 glyk\u00E9mie 6,1 mmol/l; Z-sk\u00F3re BMI 2; hladina triglycerid\u016F 1,1 mmol/l; hladina HDL-cholesterolu 1,3 mmol/l ( 1,17 mmol/l pro chlapce 15\u201319 let); hodnoty krevn\u00EDho tlaku > 95. percentil \u010Di pot\u0159eba antihypertenzn\u00ED terapie. U podskupiny z\u00E1kladn\u00EDho souboru (n = 10) jsme provedli z\u00E1t\u011B\u017Eov\u00FD test do maxima." . "Prevalence of metabolic syndrome and physical fitness in children and adolescents after renal transplantation \u2013 preliminary results"@en . . . "Prevalence of metabolic syndrome and physical fitness in children and adolescents after renal transplantation \u2013 preliminary results"@en . . "Slab\u00FD, Kry\u0161tof" . "Janda, Jan" . "5"^^ . "5"^^ . "11"^^ . "RIV/00064203:_____/10:6420" . . . "kidney transplantation; children; metabolic syndrome; prevalence; aerobic fitness"@en . . "Prevalence metabolick\u00E9ho syndromu a t\u011Blesn\u00E1 zdatnost u d\u011Bt\u00ED a dosp\u00EDvaj\u00EDc\u00EDch s transplantovanou ledvinou \u2013 p\u0159edb\u011B\u017En\u00E9 v\u00FDsledky"@cs . "Prevalence metabolick\u00E9ho syndromu a t\u011Blesn\u00E1 zdatnost u d\u011Bt\u00ED a dosp\u00EDvaj\u00EDc\u00EDch s transplantovanou ledvinou \u2013 p\u0159edb\u011B\u017En\u00E9 v\u00FDsledky" . . "1210-5481" . "Prevalence metabolick\u00E9ho syndromu a t\u011Blesn\u00E1 zdatnost u d\u011Bt\u00ED a dosp\u00EDvaj\u00EDc\u00EDch s transplantovanou ledvinou \u2013 p\u0159edb\u011B\u017En\u00E9 v\u00FDsledky"@cs . "S, Z(MZ0FNM2005)" . . "RIV/00064203:_____/10:6420!RIV11-MZ0-00064203" . . "2" . "Seeman, Tom\u00E1\u0161" . . "Radvansk\u00FD, Ji\u0159\u00ED" . . . "[084ECAB0F953]" . "Medicina Sportiva Bohemica et Slovaca" . "19" . . . "281495" . "Proch\u00E1zka, Michal" . .